Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1984 1
1986 3
1987 6
1988 7
1989 4
1990 1
1991 4
1992 3
1993 4
1994 2
1995 1
1996 2
1997 1
1998 2
2000 2
2002 2
2003 1
2006 1
2007 4
2008 2
2009 2
2010 4
2011 2
2012 4
2013 6
2014 4
2015 3
2016 4
2017 11
2018 7
2019 5
2020 5
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

103 results
Results by year
Filters applied: . Clear all
Page 1
The prevalence of narcolepsy in Catalunya (Spain).
Tió E, Gaig C, Giner-Soriano M, Romero O, Jurado MJ, Sansa G, Pujol M, Sans O, Álvarez-Guerrico I, Caballol N, Jimenez M, Becerra JL, Escartin A, Monasterio C, Molins A, Bove A, Viña J, Iranzo A, Cambrodi R, Calvo G, Morros R, Santamaria J. Tió E, et al. Among authors: molins a. J Sleep Res. 2018 Oct;27(5):e12640. doi: 10.1111/jsr.12640. Epub 2017 Nov 24. J Sleep Res. 2018. PMID: 29171110 Free article.
Status epilepticus: evidence and controversy.
García Peñas JJ, Molins A, Salas Puig J. García Peñas JJ, et al. Among authors: molins a. Neurologist. 2007 Nov;13(6 Suppl 1):S62-73. doi: 10.1097/NRL.0b013e31815bb069. Neurologist. 2007. PMID: 18090953 Review.
Drug use in patients with dementia: a register-based study in the health region of Girona (Catalonia/Spain).
Avila-Castells P, Garre-Olmo J, Calvó-Perxas L, Turró-Garriga O, Alsina E, Carmona O, Perkal H, Roig AM, Cuy JM, Lozano M, Molins A, Vallmajó N, López-Pousa S; Registry Dementia of Girona Study Group. Avila-Castells P, et al. Among authors: molins a. Eur J Clin Pharmacol. 2013 May;69(5):1047-56. doi: 10.1007/s00228-012-1451-y. Epub 2012 Nov 23. Eur J Clin Pharmacol. 2013. PMID: 23179177 Review.
Risks and benefits of generic antiepileptic drugs.
Gómez-Alonso J, Kanner AM, Herranz JL, Molins A, Gil-Nagel A. Gómez-Alonso J, et al. Among authors: molins a. Neurologist. 2008 Nov;14(6 Suppl 1):S66-72. doi: 10.1097/01.nrl.0000340793.61037.09. Neurologist. 2008. PMID: 19225372 Review.
Efficacy and tolerability of perampanel as a first add-on therapy with different anti-seizure drugs.
Santamarina E, Bertol V, Garayoa V, García-Gomara MJ, Garamendi-Ruiz I, Giner P, Aranzábal I, Piera A, Arcos C, Esteve P, Marinas A, García-Escrivá A, Viloria-Alebesque A, Loro FA, de Tienda AP, Olivan JA, Bonet M, Dávila-González P, Sivera R, Molins A, Sansa G, Roche JC, Martínez AB, Monteagudo S, Casadevall T. Santamarina E, et al. Among authors: molins a. Seizure. 2020 Dec;83:48-56. doi: 10.1016/j.seizure.2020.09.026. Epub 2020 Oct 7. Seizure. 2020. PMID: 33096456 Free article.
Effectiveness and safety of perampanel monotherapy for focal and generalized tonic-clonic seizures: Experience from a national multicenter registry.
Toledano Delgado R, García-Morales I, Parejo-Carbonell B, Jiménez-Huete A, Herrera-Ramirez D, González-Hernández A, Ayuga Loro F, Santamarina E, Toledo M, Ojeda J, Poza JJ, Molins A, Giner P, Estévez María JC, Castro-Vilanova MD, Zurita J, Saiz-Diaz RA, Gómez-Ibañez A, Rodriguez-Uranga J, Gil-Nagel A, Campos D, Sánchez-Larsen Á, Aguilar-Amat Prior MJ, Mauri Llerda JA, Huertas González N, García-Barragán N. Toledano Delgado R, et al. Among authors: molins a. Epilepsia. 2020 Jun;61(6):1109-1119. doi: 10.1111/epi.16548. Epub 2020 Jun 8. Epilepsia. 2020. PMID: 32511754
103 results